In a world now painfully aware of pandemics, with ever-increasing access to autonomous biological agents, how can we help channel society’s response to COVID-19 to minimize the risk of deliberate misuse? Using the challenge of securing DNA synthesis as an example, Kevin outlines the key norms and incentives governing biotechnology, lays out potential strategies for …